Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Exploring intentional medication non-adherence in patients with systemic lupus erythematosus: the role of physician-patient interactions.
In situ immunofluorescence analysis: analyzing RNA synthesis by 5-bromouridine-5'-triphosphate labeling.
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
In situ immunofluorescence analysis: analyzing RNA synthesis by 5-bromouridine-5'-triphosphate labeling.
In situ immunofluorescence analysis: analyzing RNA synthesis by 5-bromouridine-5'-triphosphate labeling. Methods Mol Biol. 2004; 285:29-31.
View in:
PubMed
subject areas
Antibodies
Cell Membrane Permeability
Cell Nucleus
Cells, Cultured
Cytoskeleton
Microscopy, Fluorescence
RNA
Specimen Handling
Staining and Labeling
Transcription, Genetic
Uridine Triphosphate
authors with profiles
Jitesh Pratap